- Home
- CSW vs MDGL Comparison
CSW vs MDGL Comparison
Compare CSW & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSW
- MDGL
- Stock Information
- Founded
- CSW 2014
- MDGL 2011
- Country
- CSW United States
- MDGL United States
- Employees
- CSW N/A
- MDGL N/A
- Industry
- CSW Home Furnishings
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- CSW Industrials
- MDGL Health Care
- Exchange
- CSW Nasdaq
- MDGL Nasdaq
- Market Cap
- CSW 5.2B
- MDGL 6.1B
- IPO Year
- CSW N/A
- MDGL N/A
- Fundamental
- Price
- CSW $304.81
- MDGL $314.31
- Analyst Decision
- CSW Buy
- MDGL Strong Buy
- Analyst Count
- CSW 1
- MDGL 9
- Target Price
- CSW $320.00
- MDGL $420.63
- AVG Volume (30 Days)
- CSW 123.8K
- MDGL 286.7K
- Earning Date
- CSW 07-30-2025
- MDGL 08-06-2025
- Dividend Yield
- CSW 0.35%
- MDGL N/A
- EPS Growth
- CSW 28.53
- MDGL N/A
- EPS
- CSW 8.38
- MDGL N/A
- Revenue
- CSW $878,301,000.00
- MDGL $317,383,000.00
- Revenue This Year
- CSW $22.74
- MDGL $286.17
- Revenue Next Year
- CSW $7.24
- MDGL $64.17
- P/E Ratio
- CSW $36.27
- MDGL N/A
- Revenue Growth
- CSW 10.78
- MDGL N/A
- 52 Week Low
- CSW $249.84
- MDGL $200.63
- 52 Week High
- CSW $436.50
- MDGL $377.46
- Technical
- Relative Strength Index (RSI)
- CSW N/A
- MDGL 64.53
- Support Level
- CSW N/A
- MDGL $284.02
- Resistance Level
- CSW N/A
- MDGL $311.21
- Average True Range (ATR)
- CSW 0.00
- MDGL 11.94
- MACD
- CSW 0.00
- MDGL 2.74
- Stochastic Oscillator
- CSW 0.00
- MDGL 100.00
About CSW CSW Industrials Inc. Common Stock
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.